Tissue-resident memory T cells keep cancer dormant.
作者信息
Gabriel Sarah Sharon, Kallies Axel
机构信息
Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
出版信息
Cell Res. 2019 May;29(5):341-342. doi: 10.1038/s41422-019-0156-5.
Abstract
摘要
相似文献
1
Tissue-resident memory T cells keep cancer dormant.
Cell Res. 2019 May;29(5):341-342. doi: 10.1038/s41422-019-0156-5.
2
Dormant tumor cells interact with memory CD8 T cells in RET transgenic mouse melanoma model.
Cancer Lett. 2020 Apr 1;474:74-81. doi: 10.1016/j.canlet.2020.01.016. Epub 2020 Jan 18.
3
Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanoma.
Pigment Cell Melanoma Res. 2019 Sep;32(5):612-622. doi: 10.1111/pcmr.12803. Epub 2019 Jul 8.
4
Identification of CD49a+ CD8+ resident memory T cells in vitiligo-like lesions associated with nivolumab treatment for melanoma.
J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e79-e82. doi: 10.1111/jdv.15970. Epub 2019 Oct 31.
5
Tissue-resident memory T cells in the skin.
Inflamm Res. 2020 Mar;69(3):245-254. doi: 10.1007/s00011-020-01320-6. Epub 2020 Jan 27.
6
Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Cancer Immunol Immunother. 2016 May;65(5):601-11. doi: 10.1007/s00262-016-1823-8. Epub 2016 Mar 24.
7
gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.
Clin Cancer Res. 2004 Jan 15;10(2):668-80. doi: 10.1158/1078-0432.ccr-0095-03.
8
Resident memory T cells: Runx and hide.
Sci Immunol. 2018 Jan 5;3(19). doi: 10.1126/sciimmunol.aar5172.
9
Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors.
Cancer Res. 2008 Nov 15;68(22):9451-8. doi: 10.1158/0008-5472.CAN-08-1464.
10
Maintenance of CD8 memory T lymphocytes in the spleen but not in the bone marrow is dependent on proliferation.
Eur J Immunol. 2017 Nov;47(11):1900-1905. doi: 10.1002/eji.201747063. Epub 2017 Oct 11.
引用本文的文献
1
Cytotoxic CD8+ T cells and tissue resident memory cells in colorectal cancer based on microsatellite instability and BRAF status.
World J Clin Oncol. 2021 Apr 24;12(4):238-248. doi: 10.5306/wjco.v12.i4.238.
2
Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment.
Biomark Res. 2021 Mar 1;9(1):15. doi: 10.1186/s40364-021-00265-0.
3
Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.
Int J Med Sci. 2020 Mar 5;17(6):762-772. doi: 10.7150/ijms.42151. eCollection 2020.
4
Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer.
Int J Med Sci. 2020 Jan 1;17(1):89-96. doi: 10.7150/ijms.39056. eCollection 2020.
本文引用的文献
1
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.
J Clin Oncol. 2019 Mar 1;37(7):559-569. doi: 10.1200/JCO.18.01010. Epub 2019 Jan 16.
2
Tissue-resident memory CD8 T cells promote melanoma-immune equilibrium in skin.
Nature. 2019 Jan;565(7739):366-371. doi: 10.1038/s41586-018-0812-9. Epub 2018 Dec 31.
3
Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy.
Front Immunol. 2018 Sep 11;9:2076. doi: 10.3389/fimmu.2018.02076. eCollection 2018.
4
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis.
Nat Med. 2018 Jul;24(7):986-993. doi: 10.1038/s41591-018-0078-7. Epub 2018 Jun 25.
5
Tissue-resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance.
Immunol Rev. 2018 May;283(1):54-76. doi: 10.1111/imr.12650.
6
Cancer immunotherapy using checkpoint blockade.
Science. 2018 Mar 23;359(6382):1350-1355. doi: 10.1126/science.aar4060. Epub 2018 Mar 22.
7
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.
Annu Rev Med. 2018 Jan 29;69:301-318. doi: 10.1146/annurev-med-012017-043208.
8
Cross-presentation of cutaneous melanoma antigen by migratory XCR1CD103 and XCR1CD103 dendritic cells.
Oncoimmunology. 2015 Apr 2;4(8):e1019198. doi: 10.1080/2162402X.2015.1019198. eCollection 2015 Aug.
9
New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.
Curr Opin Immunol. 2014 Apr;27:16-25. doi: 10.1016/j.coi.2014.01.004. Epub 2014 Feb 14.
10
Immune-mediated dormancy: an equilibrium with cancer.
J Leukoc Biol. 2008 Oct;84(4):988-93. doi: 10.1189/jlb.1107774. Epub 2008 May 30.
Zotero 插件